Company profile: Procyrion
1.1 - Company Overview
Company description
- Provider of catheter-based circulatory support technologies, including Aortix, a catheter-deployed pump that augments blood flow from the aortic arch to the lower aorta, reduces aortic root pressure, and increases renal perfusion to support patients with acute decompensated heart failure, renal support needs, and chronic heart failure.
Products and services
- Aortix: Engineers a catheter-deployed pump that increases blood flow from the aortic arch to the lower aorta, reduces aortic root pressure, and elevates renal perfusion for acute and chronic heart failure
- Catheter-Based Circulatory Support Technologies: Offers catheter-based circulatory support technologies intended to increase blood flow and enhance renal perfusion for patients with acute decompensated heart failure, renal support needs, and chronic heart failure
- Technology Solutions Development: Develops technology solutions focused on catheter-based circulatory support that target increased blood flow, reduced aortic root pressure, and improved renal perfusion in heart failure care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Procyrion
Edwards Lifesciences
HQ: United States
Website
- Description: Provider of heart valve science and hemodynamic monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Edwards Lifesciences company profile →
Currie Medical
HQ: United States
Website
- Description: Provider of pneumatic compression devices and garments for DVT prevention, including the ALP DVT Prevention System and VasQcare home-based DVT/PE therapy; ReCur reprocessing services for collection of single-use devices; fluid warming drapes and systems; biohazard spill kits; and medical waste solidifiers to support safety, cost savings, and environmental impact reduction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Currie Medical company profile →
Perouse Medical
HQ: France
Website
- Description: Provider of medical devices for the treatment of cardiovascular pathologies and for vascular access for intravenous therapies, specializing in long-term vascular access; part of the Vygon Group, a French group specialized in single-use medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perouse Medical company profile →
Cardiol Therapeutics
HQ: Canada
Website
- Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiol Therapeutics company profile →
Carmeda
HQ: Sweden
Website
- Description: Provider of hemocompatible surface coating for medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmeda company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Procyrion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Procyrion
2.2 - Growth funds investing in similar companies to Procyrion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Procyrion
4.2 - Public trading comparable groups for Procyrion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →